Brainstorm Cell Therapeutics, Inc. (BCLI)
0.98
-0.08
(-7.55%)
USD |
OTCM |
Aug 21, 16:00
Brainstorm Cell Therapeutics Total Liabilities (Quarterly) : 12.38M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.38M |
| March 31, 2026 | 11.76M |
| December 31, 2025 | 11.01M |
| September 30, 2025 | 9.073M |
| June 30, 2025 | 8.623M |
| March 31, 2025 | 11.03M |
| December 31, 2024 | 9.596M |
| September 30, 2024 | 8.082M |
| June 30, 2024 | 9.21M |
| March 31, 2024 | 8.898M |
| December 31, 2023 | 9.066M |
| September 30, 2023 | 8.264M |
| June 30, 2023 | 9.629M |
| March 31, 2023 | 12.71M |
| December 31, 2022 | 11.47M |
| September 30, 2022 | 11.87M |
| June 30, 2022 | 11.11M |
| March 31, 2022 | 11.30M |
| December 31, 2021 | 9.935M |
| September 30, 2021 | 9.612M |
| June 30, 2021 | 12.06M |
| March 31, 2021 | 12.37M |
| December 31, 2020 | 15.80M |
| September 30, 2020 | 6.713M |
| June 30, 2020 | 9.399M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.06M |
| December 31, 2019 | 18.76M |
| September 30, 2019 | 14.59M |
| June 30, 2019 | 13.38M |
| March 31, 2019 | 11.52M |
| December 31, 2018 | 6.212M |
| September 30, 2018 | 3.791M |
| June 30, 2018 | 8.147M |
| March 31, 2018 | 5.579M |
| December 31, 2017 | 5.543M |
| September 30, 2017 | 6.14M |
| June 30, 2017 | 0.711M |
| March 31, 2017 | 0.789M |
| December 31, 2016 | 0.864M |
| September 30, 2016 | 1.195M |
| June 30, 2016 | 1.282M |
| March 31, 2016 | 1.242M |
| December 31, 2015 | 2.952M |
| September 30, 2015 | 2.838M |
| June 30, 2015 | 2.526M |
| March 31, 2015 | 2.726M |
| December 31, 2014 | 3.236M |
| September 30, 2014 | 2.499M |
| June 30, 2014 | 1.924M |
| March 31, 2014 | 3.333M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| NovelStem International Corp. | 2.097M |
| Summit Therapeutics, Inc. | 122.20M |
| Kezar Life Sciences, Inc. | 2.762M |
| Protara Therapeutics, Inc. | 14.78M |
| Clene, Inc. | 47.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.788M |
| Shareholders Equity (Quarterly) | -11.60M |
| Debt to Equity Ratio | -0.1185 |
| Current Ratio | 0.0255 |
| Net Debt Paydown Yield | 0.72% |